BioProgress Starts Patent Action Against Stanelco

Law360, New York (October 22, 2003, 12:00 AM EDT) -- BioProgress Technology Limited, a wholly owned subsidiary of U.K. medical capsule maker BioProgress plc, Tuesday commenced proceedings against Stanelco Fibre Optics Limited, over "key" patents and patent applications, BioProgress said in a statement.

The case concerns patents for processes for encapsulation by gelatin-free polymeric materials, invented by BioProgress Technology Limited in 1998, according BioProgress. BioProgress has asked the court to issue an order to have BioProgress registered as the rightful owner of the patents and patent applications in question.

Under its generic brand XGelTM, BioProgress has...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.